BackOncoVista Innovative Therapies Overview

OncoVista Innovative Therapies Current Cash

Track OncoVista Innovative Therapies's current cash ($61K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$61270.00
↓ 18.99% YoYΔ $-14361.00 vs prior year quarter

Peer trimmed avg / median

Loading

OncoVista Innovative Therapies Current Cash History

Loading

OncoVista Innovative Therapies vs. peers: Current Cash Comparison

Loading

OncoVista Innovative Therapies Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

OncoVista Innovative Therapies (OVIT) FAQ

The latest current cash for OVIT is $61K as of September 2015. That compares with $76K in the prior-year period — down 19.0% year over year. Investors often review this figure alongside OncoVista Innovative Therapies's historical trend and sector peers before judging valuation or financial health.

Over the past year, OVIT's current cash moved from $76K to $61K — a 19.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in OncoVista Innovative Therapies's operating scale or balance-sheet position.

A current cash figure of $61K for OVIT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting OVIT's current cash ($61K), review year-over-year change from $76K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.